|
[Related PubMed/MEDLINE]
Total Number of Papers: 22
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: DA |
| Long Form |
: L-DOPA and dopamine |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2018 |
Changes in thermoregulation and monoamine release in freely moving rats during cold exposure and inhibition of the ventromedial, dorsomedial, or posterior hypothalamus. |
ACT, DMH, HR, PH, Tb, TTX, VMH |
| 2 |
2017 |
Copper-mediated DNA damage by the neurotransmitter dopamine and L-DOPA: A pro-oxidant mechanism. |
--- |
| 3 |
2014 |
Effects of acute and sub-chronic L-dopa therapy on striatal L-dopa methylation and dopamine oxidation in an MPTP mouse model of Parkinsons disease. |
COMT, l-dopa, MPTP, PD |
| 4 |
2012 |
Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson's disease. |
CDD, CDS, PD |
| 5 |
2010 |
The alpha(2) adrenoceptor antagonist idazoxan alleviates L-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats. |
i.p |
| 6 |
2008 |
Therapeutic effects of Delta9-THC and modafinil in a marmoset Parkinson model. |
PD |
| 7 |
2003 |
Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells. |
ESR, HMPE, SOD, TUNEL |
| 8 |
2003 |
DOPA cyclohexyl ester potently inhibits aglycemia-induced release of glutamate in rat striatal slices. |
alpha-MPT, AMPA, DOPA, DOPA CHE, TTX |
| 9 |
2001 |
Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma. |
DOPA, DOPAC, HVA, MAO, NB, VMA |
| 10 |
2000 |
Drug treatment of Parkinson's disease. Time for phase II. |
NQO, PD |
| 11 |
2000 |
Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson's disease. |
DOPAC, HVA, i.p, L-DOPA, NAC |
| 12 |
1997 |
Concentration of catecholamines and indoleamines in the cerebrospinal fluid of patients with vascular parkinsonism compared to Parkinson's disease patients. |
3-OMD, 5-HT, NE, PD, VP |
| 13 |
1997 |
[Evaluation of the usefulness for measuring catecholamines and their principle metabolites in the diagnosis of pheochromocytoma]. |
NA, VMA |
| 14 |
1996 |
Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. |
CNQX |
| 15 |
1995 |
Effects of chronic activation of dopamine D-2 receptors in cultures of rat fetal dopaminergic neurons: indications for alterations in functional activity. |
TH |
| 16 |
1992 |
L-dopa administration enhances exocytotic dopamine release in vivo in the rat striatum. |
L-DOPA |
| 17 |
1991 |
[Dopamine antibodies in the pathogenesis of parkinsonism]. |
--- |
| 18 |
1989 |
[The DOPA and dopamine content in the hypothalamus and brain stem of rats with an experimental stomach ulcer against a background of a course of acupuncture]. |
AP, EUS |
| 19 |
1988 |
Determinations of catechols in small volumes of plasma using ion-pair reversed phase liquid chromatography/electrochemistry. |
CA, CP-O, NA |
| 20 |
1987 |
Study on adrenergic function after development of tolerance to ethylene glycol dinitrate (EGDN) in rats. |
CA, EGDN, HR, MAP, NA |
| 21 |
1980 |
Hypothalamic catecholamine biosynthesis in vitro as measured by liquid chromatography and electrochemical detection. |
alpha mpt, LCEC, NE |
| 22 |
1979 |
gamma-Glutamyl DOPA and gamma-glutamyl dopamine: effect on plasma glucose levels. |
gamma-glutamyl DA, gamma-glutamyl DOPA |
|
A Search Service for Abbreviation / Long Form
